Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oncternal Therapeutics Inc
ONCTCurrent price
1.37 USD
-0.34 USD (-19.88%)
Last closed
1.72 USD
Company
www.oncternal.com
ISIN
US68236P1075
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
4 439 475 USD
Yield for 12 month
-79.23 %
1Y
3Y
5Y
10Y
15Y
ONCT
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins, which is in Phase 1/2 clinical trial. It is also developing ONCT-808, a chimeric antigen receptor T-cells (CAR-T), which is in Phase 1/2 clinical trial for the treatment of hematologic malignancies and solid tumors, as well as targets ROR1; and ONCT-534, a dual-action androgen receptor inhibitor product candidate in preclinical development for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The company has license agreements with the Regents of the University of California; Georgetown University; The University of Texas MD Anderson Cancer Center; Shanghai Pharmaceutical (USA) Inc.; and University of Tennessee Research Foundation. Oncternal Therapeutics, Inc. is headquartered in San Diego, California. Address: 12230 El Camino Real, San Diego, CA, United States, 92130
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
20.5 USDP/E ratio
–Dividend Yield
–Current Year
+785 000 USD
Last Year
+1 490 000 USD
Current Quarter
+801 000 USD
Last Quarter
+569 000 USD
Current Year
-28 968 000 USD
Last Year
+1 490 000 USD
Current Quarter
-5 100 000 USD
Last Quarter
-5 490 000 USD
Key Figures ONCT
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-63.09 %
PEG Ratio
–
Return On Equity TTM
-118.06 %
Wall Street Target Price
20.5 USD
Revenue TTM
1 846 000 USD
Book Value
5.32 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
655.7 %
Dividend Yield
–
Gross Profit TTM
-31 490 000 USD
Earnings per share
-12.18 USD
Diluted Eps TTM
-12.18 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ONCT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ONCT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
08.01.2024
Dividend Date
10.06.2019
Stock Valuation ONCT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.8526
Price Sales TTM
2.4049
Enterprise Value EBITDA
0.1466
Price Book MRQ
0.2818
Financials ONCT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ONCT
For 52 weeks
1.05 USD
13.2 USD
50 Day MA
2.15 USD
Shares Short Prior Month
17 887
200 Day MA
6.62 USD
Short Ratio
0.26
Shares Short
16 932
Short Percent
0.59 %
BeatStart